Page last updated: 2024-08-24

simendan and xenon

simendan has been researched along with xenon in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Autschbach, R; Bernhagen, J; Bleilevens, C; Goetzenich, A; Hatam, N; Moza, A; Preuss, S; Roehl, AB; Stoppe, C	1

Other Studies

1 other study(ies) available for simendan and xenon

Article	Year
The role of hypoxia-inducible factor-1α and vascular endothelial growth factor in late-phase preconditioning with xenon, isoflurane and levosimendan in rat cardiomyocytes. Interactive cardiovascular and thoracic surgery, 2014, Volume: 18, Issue:3 Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Animals, Newborn; Cell Hypoxia; Cell Survival; Cells, Cultured; Cytoprotection; Hydrazones; Hypoxia-Inducible Factor 1, alpha Subunit; Isoflurane; Metoprolol; Myocytes, Cardiac; Nitric Oxide Synthase Type II; Pyridazines; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction; Simendan; Time Factors; Up-Regulation; Vascular Endothelial Growth Factor A; Xenon	2014

Article

Year

The role of hypoxia-inducible factor-1α and vascular endothelial growth factor in late-phase preconditioning with xenon, isoflurane and levosimendan in rat cardiomyocytes.

Interactive cardiovascular and thoracic surgery, 2014, Volume: 18, Issue:3

Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Animals, Newborn; Cell Hypoxia; Cell Survival; Cells, Cultured; Cytoprotection; Hydrazones; Hypoxia-Inducible Factor 1, alpha Subunit; Isoflurane; Metoprolol; Myocytes, Cardiac; Nitric Oxide Synthase Type II; Pyridazines; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction; Simendan; Time Factors; Up-Regulation; Vascular Endothelial Growth Factor A; Xenon

2014